These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10317383)

  • 1. Cost/effectiveness analysis of alcoholism and drug abuse treatment programs: the relevance of recidivism and resource absorption.
    Richman A
    Eval Program Plann; 1983; 6(1):49-52. PubMed ID: 10317383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of inpatient substance abuse treatment.
    Barnett PG; Swindle RW
    Health Serv Res; 1997 Dec; 32(5):615-29. PubMed ID: 9402904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of alcohol and drug treatment programs.
    Caldwel JR
    J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
    [No Abstract]   [Full Text] [Related]  

  • 4. Documenting changes in the delivery of substance abuse services: the Status of the "100 best treatment centers for alcoholism and drug abuse" of 1988.
    Macmaster SA; Holleran LK; Chantus D; Kostyk L
    J Health Soc Policy; 2005; 20(3):67-77. PubMed ID: 16236679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple cost-benefit analysis of brief interventions on substance abuse at Naval Medical Center Portsmouth.
    Storer RM
    Mil Med; 2003 Sep; 168(9):765-8. PubMed ID: 14529255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recidivism in alcoholism and substance abuse programs. An introduction to the symposium.
    Richman A
    Drug Alcohol Depend; 1978 May; 3(3):211-3. PubMed ID: 668493
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased effectiveness of substance abuse treatment. A prospective study of patient-treatment "matching".
    McLellan AT; Woody GE; Luborsky L; O'Brien CP; Druley KA
    J Nerv Ment Dis; 1983 Oct; 171(10):597-605. PubMed ID: 6619822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using recidivism rates as a quality indicator for substance abuse treatment programs.
    Thakur NM; Hoff RA; Druss B; Catalanotto J
    Psychiatr Serv; 1998 Oct; 49(10):1347-50. PubMed ID: 9779909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matching substance abuse patients to appropriate treatments: a conceptual and methodological approach.
    McLellan AT; O'Brien CP; Kron R; Alterman AI; Druley KA
    Drug Alcohol Depend; 1980 Mar; 5(3):189-95. PubMed ID: 6766376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the economic cost of substance abuse treatment.
    French MT; McGeary KA
    Health Econ; 1997; 6(5):539-44. PubMed ID: 9353658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluations of correctional treatment programs in Germany: a review and meta-analysis.
    Egg R; Pearson FS; Cleland CM; Lipton DS
    Subst Use Misuse; 2000; 35(12-14):1967-2009. PubMed ID: 11138714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes.
    Sindelar JL; Jofre-Bonet M; French MT; McLellan AT
    Drug Alcohol Depend; 2004 Jan; 73(1):41-50. PubMed ID: 14687958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment readmissions and criminal recidivism in youth following participation in chemical dependency treatment.
    Luchansky B; He L; Longhi D; Krupski A; Stark KD
    J Addict Dis; 2006; 25(1):87-94. PubMed ID: 16597576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis and alcoholism.
    Hertzman M; Montague B
    J Stud Alcohol; 1977 Jul; 38(7):1371-85. PubMed ID: 408561
    [No Abstract]   [Full Text] [Related]  

  • 17. Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs.
    Peterson KA; Swindle RW; Phibbs CS; Recine B; Moos RH
    Med Care; 1994 Jun; 32(6):535-50. PubMed ID: 8189773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission.
    Swindle RW; Phibbs CS; Paradise MJ; Recine BP; Moos RH
    J Subst Abuse; 1995; 7(1):79-97. PubMed ID: 7655313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?
    Ettner SL; Huang D; Evans E; Ash DR; Hardy M; Jourabchi M; Hser YI
    Health Serv Res; 2006 Feb; 41(1):192-213. PubMed ID: 16430607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment services: funding and admissions.
    Butynski W
    NIDA Res Monogr; 1991; 106():20-52. PubMed ID: 1656262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.